Mammalian organogenesis involves a sequential program to generate cells with specific fates and phenotypes from a common primordium, which is hypothesized to be the consequence of regulated overlapping patterns of expression of specific sets of transcription factors in a precise spatiotemporal manner. The hypothalamic-pituitary axis is critical for survival and homeostasis, controlling growth, reproduction, metabolism and behavior, and constitutes an ideal model in which to define the molecular markers to emergence of specific cell phenotypes from a common primordium. Development of the anterior pituitary gland is controlled by sequential series of gradients of specific signaling molecules that, in turn, appear to coordinate the expression of specific combinations of transcription factor-encoding genes, many of which as tissue-specific or tissue restricted factors that serially dictate cell-type determination and terminal differentiation events that underlie the differentiated cell phenotype.
Introduction
In attaining increased freedom from the macro-environment, complex organisms regulate their homeostasis by coordinated regulatory activities of the autonomic and neuroendocrine system. These regulatory systems utilize neurotransmitters or hormones to regulate patterns of gene expression, protein synthesis and secretion in target tissues in response to the environment. The hypothalamus serves as a central regulator in these systems, coordinating signals from the environment and brain, controlling development and function of the hypophysis or the pituitary gland. Together, these organs compose the hypothalamic-pituitary axis, and are critical for homeostasis and survival. Cells of the hypothalamic-pituitary axis are postulated to acquire distinct fates in response to extrinsic signals that activate repertoires of transcription factors in a spatiotemporal manner, that determine each cell type with unique characteristics during development.
The pituitary gland consists of the adenohypophysis, which comprises the anterior and intermediate lobe and the neurohypophysis which constitutes the terminals of hypothalamic magnocellular neurons, and referred to as the posterior lobe. The anterior pituitary gland has provided an excellent model in which to investigate transcriptional control of celltype specific genes during organogenesis. The adenohypophysis develops seven distinct hormone -producing cell types which are defined by the peptide hormones that they release. Melanotropes secrete MSHb and constitute the major cell type in the intermediate lobe with corticotropes that produce adrenocorticotropin (ACTH). Both products are generated by proteolytic processing of the product of the propiomelanocortin (POMC) gene. Gonadotropes secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH) which regulate gonadal function. Thyrotropes secrete thyroid-stimulating hormone (TSH) which regulates thyroid gland size and hormone secretion. FSH, LH and TSH are heterodimeric polypeptide hormones consisting of a common a-glycoprotein subunit (aGSU) and a distinct b subunit (FSHb, LHb and TSHb) . Somatotropes secrete growth hormone (GH), which regulates growth and metabolism. Lacto-tropes synthesize prolactin (PRL) that controls milk production. In addition to these cell types, there is a transient embryonic population in the mouse arising in the rostral tip of the developing gland, which expresses the aGSU and TSHb genes (Lin et al., 1994) . However, because of these well characterized cell phenotypes, each subscribing distinct physiological role, the pituitary gland has appeared as a favorable model system in which to investigate the molecular strategies by which specific cell types emerge from a common primordium.
In this review, we focus on the signaling mechanisms and transcription factors that are proposed to regulate commitment and differentiation of the pituitary gland development and differentiation. These events can be categorized into four phases. In the first phase, (e6-e8.5), pituitary gland commitment from oral ectoderm occurs in response to inductive signals from the neuroepithelium of the developing diencephalon. The second (e8.5-e10.5) and the third phase (e10.5-e12.5), are characterized by the formation of Rathke's pouch after the invagination of the oral ecto- derm which is still in contact with the developing diencephalon and appears to involve a serial dependence on extrinsic (e6) and then intrinsic signals (Ͼe10). The final phase, (e12.5-birth), is marked by the sequential appearance of the terminally differentiated cell phenotypes of the pituitary gland (Fig. 3 ).
Signaling molecules
The pituitary gland arises as a mid-line structure, in the anterior neural ridge immediately anterior to the presumptive embryonic hypothalamus. Prior to head turn, fold and closure of the neural tube, the neural folds become considerably expanded in the head region ( Fig. 1; e6 .5). The floor of the ventral diencephalon, subsequently, becomes the primordium of the hypothalamus which will serve as a major integrating center for receiving messages from different centers and converting them to hormonal signals, via the control of the pituitary gland and by neural pathways. The pituitary gland is divided into two regions, differing in origin, structure and function; one is the diencephalic derived (hypophysis) terminal of the hypothalamic magnocellular neurons, the posterior pituitary or neurohypophysis and the second is an ectodermal derivative of the placodal ectoderm of the stomatodeal roof, the anterior pituitary or adenohypophysis ( Fig. 1; e6 .5). The primordium of the anterior pituitary gland, the Rathke's pouch, develops from the dorsal site of the junction between the ectoderm and endoderm in the roof of the primitive buccal cavity lying immediately ventral to the anterior tip of the notochord ( Fig. 1; e10) . The initial signaling functions and transcription factors that are expressed in the overlying ectoderm of the cephalic neural plate and oral ectoderm have been isolated and their roles initially defined (Fig. 3) .
Based on analogy to the developmental regulatory role for initial patterning and marginal disc development in Drosophila, the transforming growth factor b (TGFb), Wnt and Sonic Hedgehog (Shh) families have been identified in mammals, and are postulated to serve as morphogen (Hogan, 1996; Cadigan and Nusse, 1997) . Several members of these families have been studied in the development of the CNS and in the case of the ventral diencephalon, a member of the TGF family, bone morphogenetic factor-4, (BMP4) and a member of fibroblast growth factor (FGF) family, FGF8, have been noted to exert roles in late development (Jones et al., 1991; Crossley and Martin, 1995) .
Detailed ontogenic study of the pituitary gland has revealed that Shh is uniformly expressed across the oral ectoderm but becomes restricted from the invagination of Rathke's pouch (e10.5), thus creating an ectodermal boundary from which a ventral-dorsal gradient of BMP-2 later arises. Wnt5a is expressed broadly in the ventral diencephalon while BMP-4 and FGF8 are restricted in the neuroepithelium that makes contact with the Rathke's pouch. The role of these molecules in early pituitary gland development have been explored both in vivo and in vitro (Treier et al., 1998; Erickson et al., 1998) , ( Fig. 1; e11) . Using in vitro co-cultures of ventral diencephalon and oral ectoderm/ Rathke's pouch, on critical dependence diencephalon from e9-e10 was established, while subsequently (e10.5) cell determination could proceed in the absence of ventral diencephalon (Treier et al., 1998) . BMP-2/4 and Wnt5 could Fig. 1 . Pituitary gland development: pituitary is formed by the diencephalon and Rathke's pouch. Before the closure of the neural tube, at e6.5, the neuroectoderm carries the information for the future posterior pituitary gland and the ectoderm between the optic stalks will form the future anterior pituitary gland. At e10, the infudibulum develops in the floor of the third ventricle and grows ventrally toward the stomodeum. Simultaneously, an ectodermal placode appears in the roof of stomodeum and invaginates to form an invagination named Rathke's pouch, which grows dorsally toward the infudibulum. At e11, FGF8 and BMP-4 are expressed in the infudibulum exhibiting antagonistic function, whereas Wnt5a is expressed along the infudibulum and diencephalon. At e12, Rathke's pouch eventually loses its connection with the stomodeum and forms a discrete sac adjacent to the cranial surface of the infudibulum. This sac differentiates to form the anterior pituitary gland. The cells of its anterior surface give rise to the anterior lobe and a small group of cells of the posterior surface of the pouch form the intermediate lobe. BMP-2 is expressed ventrally and FGF8 dorsally. Prop-1 is expressed in a posterior to anterior gradient, whereas Brn-4 has the opposite expression pattern in the anterior pituitary gland. Meanwhile, the distal portion of the infudibulum differentiates to form the neurohypophysis or posterior pituitary gland. At e15, there is a clear definition of the structure of the gland with the simultaneous expression of Pit-1 cell lineages.
require ventral diencephalon for initial organ determination events (Erickson et al., 1998; Treier et al., 1998) .
Expression of noggin, a selective inhibitor of BMP-2 and BMP-4 (Zimmerman et al., 1996; Liem et al., 1997) , under control of Pitx-1 promoter results in a similar phenotype to the Plim/Lhx-3 − / − mouse (Sheng et al., 1996) , where the development of Rathke's pouch is arrested at the anlagen stage and only a few ACTH positive cells can be detected. Thus, pituitary gland commitment appears to require BMP-4 expressed in ventral diencephalon. Whereas, BMP-2 is required for the Pit-1 lineage (Treier et al., 1998) . Mice which misexpress a dominant-negative BMP-receptor (BMP-R1A) under the aGSU promoter gene exhibited a dwarf phenotype, with a hypoplastic pituitary gland and absence of somatotropes, lactotropes and thyrotropes. Thus, pituitary gland commitment appears to require BMP-4 and other factors, in the ventral diencephalon, whereas the subsequent ventral to dorsal BMP-2 gradient is required in the ventral pituitary gland for appearance of Pit-1 lineages. Moreover, the physiological attenuation of BMP-2 expression at e13 appears to be required for the terminal differentiation of the Pit-1 dependent cell types, because the temporally extended expression of BMP-2/4 prevents terminal differentiation in Pit-1 expressing cells, with no activation of GH, PRL and TSHb expression. FGF8, in addition to its ability to increase proliferation of the nascent pituitary gland, exerts a role in the dorsal pituitary cell type determination ( Fig. 1; e11-12 ). Overexpression of FGF8 under the aGSU regulatory elements, increases the dorsal corticotropes and melanotropes and abolishes appearance of ventral cell types such as, gonadotropes, thyrotropes, somatotropes and lactotropes (Treier et al., 1998) . Therefore, FGFs exert both proliferation and determination effects, dictating two cell types.
Coincident with these morphogenic gradients, apparent dorsal-ventral and ventral-dorsal gradients of expression of a number of transcription factors, are observed including Nkx-3.1 (Bieberich et al., 1996) Prop-1 (Sornson et al., 1996) and Pax6 (Kioussi et al., unpublished data) dorsally and isl-1, GATA-2, Brn-4 and a rostral forkhead factor (P-FRK; Treier et al., 1998) ventrally (Fig. 1; e11-12) . These genes are postulated to be targets of the signaling molecules, and in turn, are hypothesized to be required for specific aspects of cell-type differentiation programs. A corollary of these experiments is the prediction that pituitary gland cell type determination is completed by e12-e13 after the generation of an overlapping expression pattern of specific transcription factors as a consequence of the BMP-2, 4/ FGF8 gradient (Treier et al., 1998) .
Transcription factors in pituitary gland development
Pituitary cells acquire distinct fates in response to intrinsic and extrinsic signals that activate repertoires of transcription factors in a ventral-dorsal and cell specific manner which hypothesize to endow specific determination events. The number of transcription factors with known discrete temporal and spatial patterns in the developing hypothalamic -pituitary axis is large and rapidly increasing. Recently published works provide insights into the roles of specific factors in regulating generation and differ- entiation of the pituitary gland primordium to the determined organ. For instance, Rpx deletion studies in mouse show that the infudibulum and the Rathke's pouch fail to develop supporting the idea of repressor activity of this very early pituitary gland marker, whereas, analysis of mouse embryo mutants for the LIM homeobox gene Lhx3, demonstrates that this factor which is expressed in Rathke's pouch, is required for commitment of the pituitary primordium to organ fate (Fig. 3) . Subsequently, a dorsal (FGF-8 induced) to ventral (BMP-2 induced), gradient in the developing gland has been established which leads to the induction of several temporally and spatially expressed transcription factors, such as P- Frk, Brn4, Nkx3.1, Six3, respectively (Fig. 1 and Fig. 3) .
In order to begin to understand the induction of the serial determination and differentiation events, it is useful to review the known information concerning some of the transcription factors that appear during pituitary gland development. A few of the better characterized factors are discussed, based on the stages of development at which they are initially expressed.
Pituitary gland commitment (e6-e12.5)

Phase I (e6-e8.5): factors expressed in anterior midline primordium
Rpx/Hesx1
Rpx/Hesx1 is characterized by a biphasic expression during development and is the earliest known gene expressed in the anterior ridge of the pituitary primordium. Rpx/Hesx1 is expressed during gastrulation (e6) in the mid-line endoderm-mesoderm that forms the prechordal plate precursor which is involved in the induction of the anterior head structures (Hermesz et al., 1996; Thomas and Beddington, 1996; Dattani et al., 1998) . By e9, Rpx/Hesx1 is no longer detected in neuroectoderm, but is exclusively restricted to the layer of ectodermal cells which will give rise to Rathke's pouch, and at e11.5, Rpx is strongly expressed in all cells of the definitive Rathke's pouch. Rpx/Hesx1 is down regulated spatially and temporally coincident with pituitary cell differentiation, and transcripts are undetectable at e13 (Fig. 3) The progressive down regulation of Rpx/Hesx1 in a ventral to dorsal pattern, follows the cellular differentiation of the pouch. Rpx/Hesx1 expression and disappearance precedes the expression of aGSU, the first hormonal subunit found in the pituitary gland (Hermesz et al., 1996) . Fate mapping in chicken (Couly and LeDouarin, 1988) and mouse (OsumiYamashita et al., 1994) has shown that the primordium of the anterior pituitary gland is derived from the anterior ridge of the neural plate. The expressions of mouse Rpx/Hesx1 and the Xenopus counterparts Xanf1 (Zaraisky et al., 1992) and Xanf2 (Mathers et al., 1995) follow this developmental process while their expressions become restricted in the more anterior part of the cephalic neural plate. However, Xanf2 is not sufficient to drive terminal differentiation of the anterior pituitary gland after induction of its expression in animal cap explants, presumably because of the lack of signals from the underlying mesoderm (Heideveld et al., 1993) . Therefore, Rpx/Hesx1 may act as a repressor and its downregulation may be required for the proper development of the anterior pituitary gland (Hermesz et al., 1996; Sornson et al., 1996) .
Mice with deletion of the Rpx/Hesx1 locus do not develop infudibulum and the Rathke's pouch is absent in the most severe phenotypes. The floor of the hypothalamus and Rathke's pouch are characterized by expansion and abnormal bifurcations respectively (Dattani et al., 1998;  Table 2 ). Absence of Rpx/Hesx1 leads to an inadequate allocation of forebrain neuroectoderm and lack of induction of the prospective prosencephalic neuroectoderm or to a poor growth during gastrulation.
Missence mutation (Arg53Cys) within the homeodomain in the human Rpx/HESX1 gene destroys its ability to bind its DNA target and is associated with the septo-optic dysplasia (SOD) in the homozygous patients. Endocrine deficits such as GH deficiency cause pituitary hypoplasia and sexual precocity or pubertal failure due to the poor growth (Dattani et al., 1998;  Table 2 ).
Pax6 and Six-3
Studies on the Small eye mutations, Sey/Sey; a single bp mutation introducing a stop codon between the paired and homeobox of Pax6 (Stoykova et al., 1996) and Sey/Neu a single bp mutation leaving an unspliced intron and a premature translation termination signal downstream of the homeobox of Pax6 (Grinley et al., 1997) have shown that Pax6 is responsible for the final size, the normal development and the differentiation of the diencephalon. In the cerebral cortex, Pax6 is responsible for the normal migration, accumulation and enlargement of subventricular zone (Caric et al., 1997) . Pax6 transcripts are detectable in Rathke's pouch and later in the developing anterior pituitary gland (Walter and Gruss, 1991) with peak levels at e10 followed by a decrease shortly before the onset of the Pit-1 expression and pituitary gland cell lineage determination (Sornson et al., 1996) . Pax6-and Rpx/Hesx1 exhibit overlapping expression in Rathke's pouch and both genes are repressed after e12.5-e13.5. Their expression patterns correlate with early events in development (Fig. 3) .
Six-3, one of the members of the Six/sine oculis subclass of homeobox genes, is expressed early in development of the most rostral part of the anterior neural plate at e6.5, that will later give rise to non-neural ectodermal structures, including the anterior pituitary gland (Oliver et al., 1995) . Once the neural tube bends at e8.2, Six-3 expression is localized to the most rostral ectodermal derived regions such as Rathke's pouch and hypothalamus (Fig. 3) . Six3 might be involved in the early induction of the pituitary gland. These factors are likely to exert early effects that may confer later cell phenotypic decisions. 
The Otx family and relatives
POTX-1/Pitx-1, a homeobox containing gene related to the anterior-specific genes bicoid and orthodenticle in fly and Otx-1 and Otx-2 in mammals, is expressed in Rathke's pouch ectoderm immediately after the embryo turning, at e8.5 (Lamonerie et al., 1996; Szeto et al., 1996) . Pitx-1 defines a segment from which anterior pituitary gland will arise when the aGSU gene is activated. Later in development, Pitx-1 is expressed throughout the anterior pituitary gland and its rostral tip area. In vitro transfections in pituitary gland derived cell lines have shown that Pitx-1 can activate promoters of early markers of pituitary gland commitment like aGSU and markers of specific cell types such as POMC and GH and is able to synergize with Pit-1 on the PRL distal enhancer (Lamonerie et al., 1996; Szeto et al., 1996) .
A distinct but highly related factor, POTX-2/Pitx-2/Rieg is expressed early in pituitary gland development at e8.5, and its expression is maintained in the adult gland in thyrotrope, gonadotrope, somatotrope and lactotrope cell lineages, but not in corticotropes where Pitx-1 is expressed (Gage and Camper, 1997) , (Fig. 3) . The human homologue of the mouse Pitx-2 gene, RIEG, has been characterized and is responsible for Rieger syndrome (RIEG), an autosomaldominant disorder that includes abnormalities of the anterior chamber of the eye, dental hypoplasia and a protuberant umbilicus (Semina et al., 1996;  Table 2 ). RIEG is expressed in the Rathke's pouch and abnormalities of the pituitary gland such as a GH deficiency, have been associated with some cases of this syndrome (Sadeghi-Nejad and Senior, 1974) .
Otx-1 is also expressed in the pituitary gland, although only PCR data has proved such an expression. Otx-1 can activate in vitro promoters of genes encoding GH, FSHb, LHb and aGSU. Otx-1 null mice exhibit transient dwarfism and hypogonadism at the prepubescent stage due to low levels of GH, LHb and FSHb, which are restored to normal levels after 4 months of age (Acampora et al., 1998 ; Table  1 ). Otx-1 may therefore be a regulatory factor required for controlling the physiological levels of pituitary gland hormones at a postnatal stage and act directly in pituitary gland or indirectly at the level of the hypothalamus. Thus roles of these factors, alone and in combination in both early development, as well as in later function of specific cell types, should be considered.
Phase II and III (e8.5-e12.5): factors expressed in Rathke's pouch
Rathke's pouch eventually loses its connection with the stomoectoderm and starts making contact with the developing diencephalon, forming a discrete sac (LeDouarin et al., 1967) . This sac differentiates to form the anterior lobe and a small group of cells on the posterior surface of the pouch forms the functionally distinct intermediate lobe. Meanwhile, the distal portion of the infudibulum differentiates to form the posterior lobe of the pituitary gland ( Fig. 1;  e6-12 ).
Transcription factors of the homeodomain family, the LIM and paired like homeodomain factors and, zinc fingers containing families are involved in different steps of the pituitary organ determination (Fig. 3) .
The LIM homeodomain family and the definitive Rathke's pouch differentiation
At e9, Plim/Lhx3/mLim3 has a strong and uniform expression in the pouch rudiment and later in development is restricted to anterior and intermediate lobes of the pituitary gland with a peak of expression between e12 and e14 (Seidah et al., 1994; Bach et al., 1995; Zhadanov et al., 1995) . PLim/Lhx-3/mLim3 mutant mice are characterized by the lack of Rathke's pouch development and maturation further than the anlagen stage; the anterior and intermediate lobes of the pituitary gland are missing (Sheng et al., 1996 ; Table  1 ). The fact that four out of five pituitary cell types fail to appear in PLim/Lhx-3/mLim3 − / − mice, whereas only corticotropes are present, indicates that this gene is required for commitment of pituitary gland primordium to organ commitment; this is very similar to theses phenotype produced by block of BMP4 in mice (Winnier et al., 1995; Treier et al., 1998). Recently, it has been shown that PLim/Lhx-3/ mLim3 can interact directly and synergize with other factors implicated in early pituitary development. One of these factors is Pitx1 which expression is similar spatially and temporally with PLim/Lhx-3/mLim3 in the Rathke's pouch and later in the developing pituitary gland. On a common target gene, the aGSU promoter, Pitx1 and PLim/Lhx-3/mLim3 can activate synergistically the transcription. This synergy is mediated by a family of coactivators, CLIM1 and CLIM2/ NLI/Ldb1 recently characterized by their capacities to bind the LIM domain (Agulnick et al., 1996; Jurata et al., 1996; Bach et al., 1997) .
A second highly related factor, Lhx4/Gsh-4, is also expressed in early pituitary organogenesis Sheng et al., 1997) . Mice lacking Lhx-4/Gsh-4 exhibit a distinctly hypoplastic anterior lobe of pituitary (Sheng et al., 1996; Sheng et al., 1997) , while low levels of aGSU, Pit-1, GH, PRL positive cells, suggest that Lhx4/Gsh-4 is required for the proliferation of the pituitary cell precursors (Sheng et al., 1997 ; Table 1 ).
However, comparisons between the single and double homozygous mice show that differentiation of pituitary gland can be dissociated in, at least, two steps where PLim/Lhx-3/mLim3 and Lhx4/Gsh-4 are having different roles. In the first step of development from the pouch rudiment to the proper Rathke's pouch, Lhx4/Gsh-4 and PLim/ Lhx-3/mLim3 seem to play a redundant role. But later, at e15.5, in the Lhx4/Gsh-4 − / − mice, few differentiated cells are present in the pouch, suggesting that Lhx-4/Gsh-4 is not controlling the pituitary commitment but could be essential for the precursor cells proliferation where PLim/Lhx-3/ mLim3 would be essential for the transition from the Rathke's pouch stage to the proper pituitary gland. Two other LIM-homeodomain genes are expressed in the Rathke's pouch and later in the pituitary gland, isl-1 and LH2/Lhx-2, but as yet no phenotype have been described in the pituitary gland of mice lacking isl-1 (Ahlgren et al., 1997) or LH2/Lhx-2 (Porter et al., 1997) , based on their early embryonic effects.
Prophet of Pit-1 (Prop-1)
The cell autonomous Ames dwarf (d f ) mutation results in hypoplastic anterior pituitary gland, with less than 1% somatotropes and no lactotropes and thyrotropes (Gage et al., 1996) . By positional cloning, a pituitary-specific paired like homeodomain transcription factor termed Prophet-ofPit-1 (Prop-1) has been identified (Sornson et al., 1996 ; Table 1 ). The d f allele encodes a Ser to Pro mutation of the a1 helix of the Prop-1 homeodomain that results, markedly decreased affinity of the Prop-1 protein for cognate DNA sites. In Ames dwarf mice, a striking dysmorphogenesis appears at e13.5, involving expansion of the central plate cuboidal cells, a linear expansion of the laminar structure and failure of the caudomedial granular cell accumulation, areas where Pit-1 would be expressed (Sornson et al., 1996) . In addition, there is an associated loss of Pit-1 gene activation with failure of progression to mature cell types (Andersen et al., 1995; Gage et al., 1996; Sornson et al., 1996) . In addition to dysmorphogenesis, an extended expression of transcription factors such as Brn-4 and Rpx/ Hesx1 is observed beyond e15.5, suggesting that these transcription factors down regulated by Prop-1. Later markers such as the calbidin-related protein, neuronatin (Wijnholds et al., 1995) , GH, PRL and TSHb fail to be expressed due to the loss of cell determination and appearance of LHb and FSHb is delayed.
Three mutant alleles of the Prop-1 gene have been identified in four human families, establishing a common etiology for human combined pituitary hormone deficiency characterized by GH, PRL and TSH deficiency (Wu et al., 1998 ; Table 2 ). Many individuals with PROP-1 mutation also exhibit impaired production of LH and FSH and do not enter the puberty spontaneously. Mutations of the human PROP-1 gene result in a gene product with reduced DNAbinding and transactivation ability or total loss of the DNA binding domain. A nucleotide transition causes substitution of Arg to Cys in the third helix of the homeodomain and a 2 bp deletion results in a frameshift of the coding sequence and the loss of the DNA-binding homeodomain and C-terminal transactivation domain of Prop-1. A T to A transversion results in a Phe 117, a part of the core DNA binding motif of the homeodomain. The lack of GH, PRL and TSH, in addition to the gonadotropin deficiency in these pedigrees is in correlation with the delayed expression of gonadotropes and compromised levels of GH, PRL and TSH in the mature d f mouse, indicating that the role of Prop-1 is conserved from mice to humans. This gene thus appears to be required to permit asymmetrical cell division, under which generates the Pit1 lineage from a precursor population.
Pituitary cell differentiation
Phase IV (e12.5-birth): factors expressed in determined cell types
During development, seven individual hormone-producing cell types arise within restricted regions of the developing gland, with a very well conserved pattern throughout vertebrates. The first cell types to appear at e11 in the developing pituitary gland are the corticotropes in an adjacent intermediate domain and TSHb positive cells in the rostral tip (Begeot et al., 1982) , (Fig. 1 and Fig. 2) . About the same time intermediate lobe melanotropes appear. Cells of the anterior lobe differentiate only at later stages and generate the second population of thyrotropes, the somatotropes, lactotropes and gonadotropes.
Two independent cell populations express the aGSU and TSHb genes. The first population is Pit-1-independent, appearing at e11 in the rostral tip of the gland, persists throughout ontogeny, and phenotypically disappears at birth. The second, dependent upon functional Pit-1, arises subsequently in the caudomedial part of the gland at e15.5 and follows the initial expression of Pit-1 in this region (Lin et al., 1994) (Fig. 3) .
Pit-1 /GHF1
The Pit-1 gene encodes a POU domain transcription factor that was originally identified, and cloned based on its ability to bind to and transactivate the GH and PRL genes (Bodner et al., 1988; Ingraham et al., 1988) . Two of several mouse natural mutations, Snell (dw) and Jackson (dw J ), characterized by a dwarf phenotype, are due to mutations in the Pit-1 gene (Li et al., 1990) . Phenotypically, the anterior pituitary gland of dw and dw J mice is markedly hypoplastic with deficiencies in GH, PRL and TSHb and contains only gonadotrope, melanotrope and corticotrope cells. Several Pit-1 mutations have also been described in humans with similar phenotype such as found in d w and dw J dwarf mice (Pfaffle et al., 1992;  Table 2 ).
Pit-1 appears to be essential for the differentiation and survival of somatotropes, lactotropes and thyrotropes, except for a part of the thyrotrope population which developed earlier in the rostral tip at e11 but disappeared by the day of birth (Lin et al., 1994) . Moreover, Pit-1 is able to regulate directly the expression of the hormones produced by these cell types, GH, PRL, TSHb. Pit-1 is also an autoregulated transcription factor (Chen et al., 1990; McCormick et al., 1990 ) with a critical enhancer located 10 kb upstream and its late expression depends on this autoregulatory loop (Rhodes et al., 1993) . In Pit-1 mutant mice, Pit-1 is normally activated at e13.5, but because the Pit-1 protein is non-functional, there is no autoregulation and expression of Pit-1 gene declines between e15.5-e16.5 . In the Ames dwarf mice, the Pit-1 gene is never activated. Another region downstream of the autoregulatory enhancer is responsible for the early activation of the gene (Sornson et al., 1996) . Which factors are responsible for early activation have not yet been characterized but Prop-1 remains a candidate (Andersen et al., 1995; Sornson et al., 1996) .
Krox-24/NGFI-A/Egr-1/zif268: a zinc finger immediate-early response gene
Krox-24/NGFI-A/Egr-1/zif268 is expressed at e14.5 in the anterior pituitary gland with a dramatic increase in expression birth (Topilko et al., 1997) . In the Krox-24/NGFI-A/ Egr-1/zif268 − / − mice, somatotropes present abnormal cytological features and are reduced in number, consistent with the decreased GH levels. However, gonadotropes are normal in number but female mice are infertile due to the failure to synthesize LHb Topilko et al., 1997 ; Table 1 ).
Transcription factors in hypothalamus development
The hypothalamus contains a large number of well defined neuronal circuits that regulate vital functions including temperature, heart rate, blood pressure, osmolarity, water and food intake as well as the release of hypothalamic neuropeptides that regulate gene expression, proliferation and hormonal secretion of the pituitary cell types. Axons of the magnocellular neurosecretory system including paraventricular (PVH) and supraoptic (SO) nuclei that synthesize the peptide hormones oxytocin (OT) or arginine vasopressin (AVP), arising from the hypothalamus, terminate in the posterior lobe of the pituitary gland. Axons of the parvocellular system, the second neurosecretory system of hypothalamus, deliver tropic hormones to the median eminence where they are transported to the anterior pituitary for the initiation, synthesis and release of tropic hormones. Identification and functional studies of hypothalamic specific factors suggest that there is coordination in development of the hypothalamic -pituitary axis, which requires parallel actions of genes expressed in both organs.
Nkx2.1/Tebp/TTF-1
The thyroid enhancer binding protein also referred as thyroid specific transcription factor or Nkx2.1/Tebp/TTF-1, was originally described as being able to control thyroid specific expression of the rat thyroglobulin gene (Civitareale et al., 1989) . Nkx2.1/Tebp/TTF-1 expression is restricted in the hypothalamus, in a dorsoventral gradient in the neuroepithelium with higher expression in the ventral region and in the posterior pituitary gland but not in Rathke's pouch (Kimura et al., 1996) . Nkx2.1/Tebp/TTF-1 null mice lack selective hypothalamic nuclei such as the premammilary and arcuate nucleus and the mammilary body and supramammilary nucleus of the posterior hypothalamus (Kimura et al., 1996;  Table 1 ) whereas the entire pituitary gland is absent. Apparently, the presence of Nkx2.1/Tebp/ TTF-1 in the ventral infudibulum and the hypothalamus is responsible for neuronal induction that in time are required for development of Rathke's pouch.
Brn-2 and SIM1
The developing hypothalamus contains zones of cells that express specific combinations of POU homeodomain proteins including 'Brn-2 only', 'Brn-4 only', 'Brn-1 only', and 'Brn-2 and Brn-4' cells, which form anatomical boundaries. Brn-2 and Brn-4 are coexpressed in defined neuronal cell types in the presumptive PVH and SO nuclei (Schonemann et al., 1995) . Targeted disruption of the Brn-2 gene (Nakai et al., 1995; Schonemann et al., 1995;  The bHLH-PAS transcription factor SIM1 is expressed during development in PVH, anterior periventricular (aPV) and SO nuclei. Homozygous mutant mice characterized by absence of oxytocin, vasopressin, thyrotropin-releasing hormone, corticotropin-releasing hormone and somatostatin in PVH, aPV and SO and the prospective PVH/So region fail to express Brn-2 which suggests that SIM1 is genetically upstream to Brn-2 (Michaud et al., 1998) .
Nhlh2
Nhlh2, a member of the basic helix-loop-helix (bHLH) family is expressed in the developing hypothalamus and in both embryonic and adult pituitary gland (Good et al., 1997) . There is a clear link between Nhlh2 expression along the Hypothalamic-pituitary axis and the phenotype of the Nhlh2 − / − mice. Male mutant mice are hypogonadal, and infertile due to the alternated levels of circulating testosterone, defects in spermatogenesis and loss of sexual behavior (Good et al., 1997) . Female mutant mice are hypogonadal but after exposure to males, their reproductive system developed and is fertile again. Both males and females exhibit progressive adult obesity (Good et al., 1997 ; Table  1 ).
SF-1
Nuclear steroidogenic Factor 1 (SF-1; Lala et al., 1992; Ingraham et al., 1994) or adrenal 4-binding protein (Honda et al., 1993) encodes the Ftz-F1 gene which is expressed in adrenal and gonadal tissues and diencephalon during development (Guili et al., 1997) Ftz-F1 null mutant mice lack adrenal glands, gonads and the female are characterized by internal genitalia which initially develop gonads but then regressed by programmed cell death , and three gonadotrope specific markers, LH, FSH and gonadotropin releasing hormone (GnRH) are missing from the pituitary gland (Ingraham et al., 1994) .
SF-1 regulates both hormones that are essential for male sexual differentiation, androgens and Müllerian inhibiting substance (MIS) and its expression in the embryonic ventral diencephalon makes it an essential player for the multiple levels of the reproductive axis development, including the steroidogenic organ development and sexual differentiation (Nachtigal et al., 1998;  Table 1 ).
Gsh-1
Gsh-1 is expressed in the Hypothalamic-pituitary axis (Valerius et al., 1995) and Gsh-1 protein has the ability to bind to the growth hormone releasing hormone (GHRH) promoter. Gsh-1 − / − mice never reach the normal adult body size, are sexually infantile and infertile and exhibit hypoplastic pituitary gland dwarfism due to GH insufficiency (Li et al., 1996 ; Table 1 ). The pituitary gland defect in Gsh-1 mutants is thought to be secondary to the absence of GHRH in the arcuate nucleus, resulting in lack of GH release from the pituitary gland.
Non-transcriptional factors
Upstream of GHRH
GHRH is synthesized in the arcuate nucleus of hypothalamus, released into the median eminence and transported to the anterior pituitary gland by a portal circulatory system. GHRH regulates GH secretion and controls somatotropes proliferation and survival (Barinaga et al., 1983) . A mutation in the GHRH receptor that leads to somatotropes hypoplasia and dwarfism show the importance of this action in the little mice . GHRH mediated somatotropes proliferation requires activation of cAMP signaling, while lactotropes maintenance is negatively controlled by dopamine-mediated inhibition of the same pathway.
The dopamine receptor and its transporter
The secretion of POMC by the melanotropes in the intermediate lobe of the pituitary gland is controlled by a combination of dopaminergic inhibition through D 2 receptors and other secretagogues. Dopaminergic D 2 receptors also inhibit prolactin secretion, whereas estrogen induces lactotropes proliferation. Mice lacking dopamine D 2 receptors have progressive lactotropes hyperplasia, which ultimately leads to tumors in aged female animals (Kelly et al., 1997; Saiardi et al., 1997;  Table 1 ).
Termination of dopaminergic action is achieved via the dopamine transporter located on the membrane of the hypothalamic dopaminergic neurons. Mice lacking the dopamine transporter are hyperactive due to the protracted duration of dopamine action in dopaminergic synapses. Female mutant mice are incapable of nursing their babies and all of them show significant growth retardation compare with wild type litter mates (Giros et al., 1996;  Table 1 ). All of them have decreased GHRH expression, which is under the inhibitory dopaminergic control. Over-stimulation of D 2 receptors in the pituitary gland results a decrease of Pit-1 in the adult pituitary gland of these animals resulting in a hypoplastic gland due to selective loss of somatotropes and lactotropes (Bosse et al., 1997) .
Conclusions
The pituitary gland based on the extensive differentiation of the cell types has provided a favorable model to explore molecular mechanisms by which distinct cell phenotypes emerge from a common primordium. In this case, following signals for invagination from a common oral ectoderm, an ectodermal Shh boundary is established with contact with the neuroepithelium and signals including FGF, BMP, and Wnts from the ventral diencephalon. The subsequent generation of opposing ventral → dorsal, dorsal → ventral BMP and FGF8 gradients, respectively, which act early in organogenesis to generate a spatial map of cell-type determination along ventral → dorsal gradients. Thus, gonadotropes are most ventral followed by thyrotropes and lactotropes as ventral cell-types with both corticotropes and melanotropes arising as FGF-dependent dorsal celltypes. The elucidation of overlapping gradients of transcription factors strongly suggests that, alone or in combination, these serve to mark the gradients of signaling molecules, and dictate cell type determination. In turn, a specific factor (Prop-1) is required to generate the Pit-1 lineage out of the driving periluminal cell population, controlling a ventral asymmetrical cell population, and is epistatic to Pit-1, which is directly required but not sufficient to activate distal target genes in the three Pit-1 dependent pituitary cell types -somatotropes, corticotropes and thyrotropes. This model system therefore has been ideally suited to establish the signaling gradient and potentially combinatorial code of the anatomical and signaling factors required for cell type specification. This model is further suited to define the role of spatial determination vs. cellular commitment and the mechanisms of cell type-restriction that permit the emergence of phenotypically distinct cell types critical for homeostasis from a mid-line primordium.
